Corporate
Aug. 24, 2005
Merck Plans to Defend Vioxx One Suit at a Time
LOS ANGELES - Despite last week's $253-million verdict against Vioxx-maker Merck Co., the pharmaceutical giant says it remains determined to defend one by one each of the thousands of individual lawsuits over its controversial painkiller.




To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In